Emollients: risk of severe and fatal burns

The MHRA have issued new warnings about fire & burns risk with emollients. The new warnings state that ALL emollients may pose a risk of severe and fatal burns – regardless of paraffin content or concentration. The MHRA provide the following advice for healthcare professionals: there is a fire risk with all paraffin-containing emollients, regardless of paraffin concentration, and it Continue Reading »

Consultation events on items which should not routinely be prescribed in primary care

As part of our latest consultation on items which should not routinely be prescribed in primary care the following events are taking place. They will outline proposals for updated CCG guidance, including more effective, safer and/or cheaper alternative items. Please encourage colleagues, GP practices and lay members to book their place: Tuesday 8 January, 12:00-13:00, CCG Medicines optimisation leads Continue Reading »

Flash glucose monitoring

NHS England recently announced that flash glucose monitors will be available on prescription for every patient who qualifies for them, in line with NHS clinical guidelines. This action will end the current variation some patients with Type 1 diabetes are facing. Currently, it is estimated that around 3-5% of patients with Type 1 diabetes in England have access Continue Reading »

Antibiotic Allergy – Mislabelling Contributes to Resistance

The Lancet has published a global update on antibiotic allergy epidemiology, classification, mechanisms, and management – highlighting the public health importance of reported/recorded penicillin allergy. Antibiotics are the commonest cause of life-threatening immune-mediated drug reactions that are considered off-target, including anaphylaxis, and organ-specific and severe cutaneous adverse reactions. However, many antibiotic reactions documented as allergies were unknown or not Continue Reading »